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Introduction
Tumor cells invade 3D ECM as individual cells or as collective 
sheets and strands (Friedl and Alexander, 2011). Both individual 
and collective cell migrations have been documented in vivo, 
and together, these strategies play an important role in escape 
from the primary tumor and seeding of metastases (Sahai, 2007; 
Friedl and Alexander, 2011).
Cell migration is well studied within the context of 2D 
planar substrates, with clear roles described for RhoGTPases 
such as Rac in establishing and maintaining a broad ruffling la-
mellipodium at the cell front and for RhoA in controlling acto-
myosin contractility and retraction of the cell rear (Ridley et al., 
2003). Individual cell-invasive migration has been broadly cate-
gorized as mesenchymal (protease dependent with protrusion 
driven by Rac and/or Cdc42) or amoeboid (exhibiting little pro-
tease dependence with protrusion driven by RhoA-mediated ac-
tomyosin contractility and blebbing; Friedl and Alexander, 
2011). The cycling of RhoGTPases between active and inactive 
states is controlled by GTPase-activating proteins (GAPs) and 
guanine nucleotide exchange factors (GEFs), which can deter-
mine the reciprocal relationship between RhoA and Rac activi-
ties (Guilluy et al., 2011). In invasive melanoma cells, specific 
GAPs and GEFs balance the activities of Rac and RhoA to con-
trol switching between modes of migration in 3D (Sanz-Moreno 
et al., 2008). The use of Förster resonance energy transfer 
(FRET)–based activity probes has revealed the spatiotemporal 
activities of RhoGTPases to be highly complex, with active 
RhoA seen at the cell front on 2D substrates (Pertz et al., 2006; 
Machacek et al., 2009). Furthermore, in 3D matrix and in vivo, 
highly invasive mutant p53-expressing pancreatic cancer cells 
with a clear elongated morphology have high levels of RhoA 
Inhibition of v3 or expression of mutant p53 promotes invasion into fibronectin (FN)-containing extracellular matrix (ECM) by enhancing Rab-coupling protein 
(RCP)–dependent recycling of 51 integrin. RCP and 51 
cooperatively recruit receptor tyrosine kinases, including 
EGFR1, to regulate their trafficking and downstream signal-
ing via protein kinase B (PKB)/Akt, which, in turn, promotes 
invasive migration. In this paper, we identify a novel PKB/
Akt substrate, RacGAP1, which is phosphorylated as a con-
sequence of RCP-dependent 51 trafficking. Phosphoryla-
tion of RacGAP1 promotes its recruitment to IQGAP1 at the 
tips of invasive pseudopods, and RacGAP1 then locally sup-
presses the activity of the cytoskeletal regulator Rac and pro-
motes the activity of RhoA in this subcellular region. This Rac 
to RhoA switch promotes the extension of pseudopodial 
processes and invasive migration into FN-containing matri-
ces, in a RhoA-dependent manner. Thus, the localized en-
docytic trafficking of 51 within the tips of invasive 
pseudopods elicits signals that promote the reorganization 
of the actin cytoskeleton, protrusion, and invasion into 
FN-rich ECM.
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trafficking and signaling. Phosphorylation of RacGAP1 on T249 
does not influence formation of the centralspindlin complex 
but promotes recruitment of RacGAP1 to IQGAP1-containing 
complexes within the tips of invasive pseudopods. RCP-driven 
51 recycling suppresses Rac activity through the RacGAP1–
IQGAP1 complex and permits the concomitant activation of 
RhoA. Surprisingly, suppression of Rac is necessary and suf-
ficient to promote pseudopod extension and invasive migration 
in 3D, both of which require RhoA activity, identifying a novel 
pathway that regulates the acquisition of an elongated mode of 
individual cell migration into FN-rich ECM.
Results
RacGAP1 is a novel PKB/Akt  
substrate phosphorylated downstream of 
RCP–51-mediated RTK signaling
We have previously shown that inhibition of v3 integrin 
(using cRGDfV, a selective cyclic peptide inhibitor of v3) 
promotes RCP-dependent trafficking and signaling via PKB/
Akt to induce extension of pseudopodial protrusions in 3D 
matrix (Caswell et al., 2008). To localize PKB/Akt activity, 
we used the FRET probe Akind (Yoshizaki et al., 2007). Only 
low levels of PKB/Akt activity were detectable in A2780 
cells migrating on cell-derived matrix (CDM) under basal 
conditions (compared with inactive Akind-3A; Fig. 1 A and 
Fig. S1 A). Inhibition of v3 promoted activation of PKB/
Akt at the front of cells migrating with RCP–51-driven 
pseudopodia (Fig. 1 A). Furthermore, suppression of PKB/
Akt2 greatly reduced RCP–51-driven invasion (Fig. S1, 
B and C), in line with previous findings (Irie et al., 2005; Dillon 
et al., 2009).
We next sought to identify the PKB/Akt targets required 
for invasion downstream of RCP–51. Immunoprecipitation 
(IP) using an antibody recognizing the phosphorylated PKB/
Akt consensus sequence (RxRxxS*/T*) revealed putative 
PKB/Akt substrates of 75–85 kD enriched upon addition of 
cRGDfV (unpublished data). Mass spectrometry (MS) analy-
sis of proteins within this molecular mass range, combined 
with hierarchical clustering of spectral count data, identified 
a subset of proteins that were hyperphosphorylated upon 
cRGDfV stimulation, with RacGAP1 (also known as MgcRac-
GAP or hCYK-4) showing the highest increase after cRGDfV 
addition (Fig. 1 B).
RacGAP1 is a Rac- and Cdc42-specific GAP and plays a 
critical role in the regulation of RhoGTPases during cytokinesis 
(Canman et al., 2008; Bastos et al., 2012). This led us to specu-
late that RacGAP1 could constitute a central link between 
RCP–51-mediated trafficking and signaling and RhoGTPase 
cytoskeletal regulators. In vitro phosphorylation, using purified 
mannose-binding protein (MBP)–RacGAP1 and recombinant 
active PKB/Akt, established RacGAP1 as a direct substrate for 
PKB/Akt (Fig. 1 C). Moreover, immunoblotting of PKB sub-
strates captured using the RxRxxS*/T* antibody demonstrated 
that RacGAP1 phosphorylation was promoted by cRGDfV ad-
dition and was significantly reduced by the broad spectrum ki-
nase inhibitor staurosporine (Fig. 1 D).
activity at the cell front (Timpson et al., 2011), suggesting that 
mesenchymal invasion dependent on mutant p53 could be 
driven by RhoA.
The interaction between invading cells and the surround-
ing ECM is governed by integrins, which act as receptors for 
ECM proteins (Humphries et al., 2006). Integrins are / het-
erodimers that function to link the ECM to the cytoskeleton, 
recruiting a range of signaling molecules to regulate cellular 
function such as cell migration, and RhoGTPases are key effec-
tors of integrin signaling (Hynes, 2002; Huveneers and Danen, 
2009; Legate et al., 2009). Integrin function is regulated by the 
binding of intracellular factors, such as talin and kindlins, which 
control integrin activation (Moser et al., 2009; Shattil et al., 
2010). In addition, integrins are internalized from the plasma 
membrane, and endosomal sorting determines the degradation 
or recycling of the receptor (Caswell et al., 2009; Wickström 
and Fässler, 2011; Bridgewater et al., 2012). Integrin recycling 
can be targeted to specific regions of the cell and can therefore 
control propagation of intracellular signals in a localized man-
ner (Caswell et al., 2008, 2007; Dozynkiewicz et al., 2012; 
Rainero et al., 2012). The pathways that regulate integrin traf-
ficking have been implicated in many aspects of cell migration 
in 2D, and accumulating evidence indicates that the trafficking 
of integrins, particularly the fibronectin (FN) receptor 51, 
can dictate the migratory properties of invasive cancer cells 
(Caswell and Norman, 2008).
In fibroblasts and tumor cells, inhibition of v3 (or 
v3 recycling) promotes the recycling of 51 and rapid, 
random migration in 2D (White et al., 2007; Caswell et al., 
2008; Christoforides et al., 2012). Similarly, in carcinoma 
cells, expression of gain-of-function mutant p53 can switch 
on a rapid 51 recycling pathway (Muller et al., 2009). Rab-
coupling protein (RCP; also known as Rab11-FIP1) is central 
to the control of 51 recycling in these contexts and drives 
pseudopod extension and invasion into FN-rich 3D matrix 
(Caswell et al., 2008; Muller et al., 2009). RCP-mediated 
51 recycling does not influence adhesion; rather, RCP and 
51 act by recruiting receptor tyrosine kinases (RTKs), e.g., 
EGFR1 and c-Met, and coordinating the recycling of associ-
ated RTKs to potentiate their signaling via PKB/Akt (Caswell 
et al., 2008; Muller et al., 2009, 2013). Production of phospha-
tidic acid (PA) by DGK- (diacylglycerol kinase ) localizes 
RCP and, as a consequence, 51/RTK trafficking toward the 
front of invading cells, providing a spatial cue for protrusion 
(Rainero et al., 2012). Although it is clear that the RhoA–Rho 
kinase (ROCK)–cofilin pathway controls the rapid, random 
migration of fibroblasts (White et al., 2007) and that RCP- 
dependent integrin trafficking influences invasive migration via 
effects on RTK trafficking and signaling (Caswell et al., 2008; 
Muller et al., 2009, 2013), the mechanisms through which RCP–
51-mediated RTK trafficking and signaling impact upon the 
cytoskeleton to promote pseudopodial extension at the cell front 
and migration in 3D matrix are not known.
Here, we describe RacGAP1 (also known as MgcRacGAP 
or hCYK-4), a component of the centralspindlin complex, as 
a novel PKB/Akt substrate that is phosphorylated on threo-
nine (T) 249 as a consequence of RCP-driven 51/EGFR1 
919Local Rac suppression promotes pseudopod extension • Jacquemet et al.
(Muller et al., 2009), and depletion of RacGAP1 levels in these cell 
lines significantly reduced invasive migration (Fig. 2, E and F; 
and Fig. S1, M–O). These data demonstrate that RacGAP1 is 
required for RCP–51-dependent invasive migration in sev-
eral cell lines.
Phosphorylation of RacGAP1 on T249 
promotes recruitment to IQGAP1
MS analysis of in vitro phosphorylated MBP-RacGAP1 and 
FLAG-RacGAP1 immunoprecipitated from 293T cells iden-
tified a single predominant PKB/Akt phosphorylation site in 
RacGAP1 but could not distinguish between T249 (within 
the sole PKB/Akt consensus within RacGAP1, previously 
reported in MS analysis; Moritz et al., 2010) and T251 (un-
published data). In vitro phosphorylation using recombinant 
active PKB/Akt, with either putative phosphorylation site mu-
tated to alanine, revealed T249 to be the predominant PKB/Akt 
phosphorylation site within RacGAP1 (Fig. 3 A). We generated 
RacGAP1 is required for RCP–51-driven 
pseudopod extension and invasive migration
We next tested the functional importance of RacGAP1 in 3D 
cell migration. RCP–51-driven pseudopodial migration leads 
to increased invasive capability within dense plugs of high con-
centration collagen I rich in the 51 ligand FN (Fig. 2, A–C; 
Caswell et al., 2008). RacGAP1 knockdown (Fig. S1 D) had no 
significant effect on the speed or persistence of cells migrating 
on CDM or on the formation of protrusions under basal condi-
tions (Fig. 2, A and B; and Fig. S1, F and G). Upon cRGDfV 
stimulation, however, RacGAP1-depleted cells were unable to 
extend invasive pseudopods (Fig. 2, A and B; and Fig. S1 H). 
Moreover, RacGAP1 knockdown specifically reduced cRGDfV-
driven invasion into FN-rich ECM (Fig. 2 C and Fig. S1 I), and 
this was rescued by expression of siRNA-resistant RacGAP1 
(Fig. 2 D and Fig. S1 L). Expression of mutant forms of p53, ei-
ther endogenously (MDA-MB-231 cells) or exogenously in H1299 
cells, promotes invasion via RCP–51-dependent trafficking 
Figure 1. RacGAP1 is a PKB/Akt substrate required for pseudopod extension and invasion. (A) A2780 cells expressing Akind on CDM were stimulated 
with 2.5 µM cRGDfV as indicated. Fluorescence lifetime images were captured, and representative lifetime maps are shown. FRET efficiency was calculated 
for ROI (dotted lines). The yellow line represents the baseline activity as determined by an inactive mutant of the probe. Bar, 10 µm (n > 18/condition). 
(B) PKB/Akt substrates were immunoprecipitated (IP) using anti-RxRxxS*/T* from lysates of EGF-stimulated cells treated with cRGDfV as indicated. IPs 
were separated by SDS-PAGE and analyzed by MS/MS. Hierarchical clustering of identified proteins is shown, with increasing abundance indicated by 
intensity. RacGAP1 is indicated with an asterisk. (C) Purified MBP-RacGAP1 was incubated in in vitro phosphorylation reactions as indicated. Proteins were 
separated by SDS-PAGE, protein loading was confirmed by Coomassie staining, and incorporation of radioactive ATP was measured by a phosphorim-
ager. (D) Lysates of EGF-stimulated A2780 cells treated with cRGDfV and staurosporine as indicated were subjected to IP using anti-RxRxxS*/T* as in B or 
an isotype-matched control. IPs were analyzed by SDS-PAGE and Western blotting for RacGAP1 and quantified using the Odyssey system. Data represent 
means ± SEM from at least three independent experiments. *, P < 0.05; **, P < 0.001.
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(Fig. S1 J). Furthermore, these cell lines showed prolifera-
tion rates equivalent to control, suggesting that they are fully 
functional during cytokinesis when expressed at this level 
stable FLAG-RacGAP1–expressing A2780 cells using lentivi-
ral transfection and noted that cells expressing wild-type (WT) 
or mutant RacGAP1 lost endogenous RacGAP1 expression 
Figure 2. RacGAP1 is required for pseudopod extension and invasion. (A) A2780 cells were transfected with control or RacGAP1-specific SMARTpool 
oligonucleotides, seeded onto CDMs, and stimulated with cRGDfV as indicated. Images were captured every 10 min using a 20× objective lens. Repre-
sentative images are shown. Bar, 50 µm. (B) Pseudopod length (n > 400/condition) was measured for all moving cells within the 20th frame. (C) A2780 
cells were transfected as in A and seeded into inverted invasion assays after 16 h in the presence or absence of FN and cRGDfV as indicated. The yellow 
line indicates the level of invasion under control conditions. (D) A2780 cells stably expressing GFP or FLAG-RacGAP1WT were transfected with control or 
RacGAP RNAi oligo #6, treated as in C, and seeded into inverted invasion assays in the presence of cRGDfV and FN. (E) MDA-MB-231 cells were trans-
fected as in A and seeded into inverted invasion assays in the presence of FN. (F) H1299 cells stably expressing mutant p53 (273H) or control vector (VEC) 
were transfected as in A and seeded into inverted invasion assays in the presence of FN. Data represent means ± SEM from at least three independent 
experiments. *, P < 0.05; **, P < 0.01; ***, P < 0.001.
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with MKLP1 (mitotic kinesin-like protein 1) and Ect2, which 
were unaltered by treatment with cRGDfV or by mutation of 
T249 (Fig. 3 C). Hence, PKB/Akt-mediated phosphorylation 
of RacGAP1 at T249 has no influence on formation of the cen-
tralspindlin complex or its recruitment of Ect2.
We recently showed that the cytoskeletal adaptor pro-
tein IQGAP1 recruits RacGAP1 to sites of integrin activation 
in fibroblasts, to restrict the activity of Rac as cells spread on 
FN (Jacquemet et al., 2013b). In A2780 cells, little association 
was seen between endogenous IQGAP1 and RacGAP1; how-
ever, stimulation with cRGDfV increased IQGAP1–RacGAP1 
(Fig. S1 K). IP with PKB/Akt substrate-specific antibodies 
revealed that phosphorylation of FLAG-RacGAP1 was in-
creased by addition of cRGDfV, and this was opposed by mu-
tation of RacGAP1’s T249 to alanine (Fig. 3 B and Fig. S2 K). 
Collectively, these data suggest that T249 is the major PKB/
Akt phosphorylation site within RacGAP1.
T249 is situated within a region of RacGAP1 that is pre-
dicted to be unstructured (Fig. S1 E). Nevertheless, we deter-
mined the consequences of mutating T249 on the recruitment of 
known interactors (Mishima et al., 2002; Yüce et al., 2005). IP of 
FLAG-RacGAP1WT from A2780 cells revealed robust associations 
Figure 3. RacGAP1 phosphorylation on T249 
promotes association with IQGAP1. (A) Purified 
MBP-RacGAP1 and mutants were subjected to 
in vitro phosphorylation and incorporation of 
33P measured as in Fig. 1 C. (B) PKB/Akt sub-
strates were immunoprecipitated from lysates of 
A2780 cells stably expressing GFP, FLAG-Rac-
GAP1, or FLAG-RacGAP1249A as in Fig. 1 D. 
(C) Lysates of A2780 cells stably expressing 
GFP(), FLAG-RacGAP1, FLAG-RacGAP1249A, 
or FLAG-RacGAP1249D were subjected to IP 
using FLAG antibodies. IPs were analyzed by 
SDS-PAGE and Western blotting for FLAG, 
Ect2, and MKLP1. (D) Lysates of A2780 cells 
were subjected to IP using rabbit IQGAP1 anti-
bodies or an isotype-matched control. IPs were 
analyzed by SDS-PAGE and Western blotting 
for RacGAP1 and IQGAP1. (E) Cells as in C 
were lysed, and IP was performed using rab-
bit IQGAP1 antibodies. IPs were analyzed 
by SDS-PAGE and Western blotting for FLAG 
and IQGAP1. (F) Western blots from IPs as 
in E were quantified using the Odyssey sys-
tem. (G) Cells stably expressing GFP, FLAG-
RacGAP1WT, or FLAG-RacGAP1249A on CDM 
were treated with cRGDfV for 1 h and fixed 
and stained with antibodies against FLAG and 
IQGAP1 before performing PLA. PLA signal 
was quantified by measuring the integrated 
density within the whole cell using ImageJ (n > 
60/condition). Zoomed insets correspond to 
areas indicated by dotted ROIs. Bars, 20 µm. 
Data represent means ± SEM from at least 
three independent experiments. *, P < 0.05; 
**, P < 0.01; ***, P < 0.001.
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and Fig. S2, A–C). IQGAP1 knockdown cells were unable to 
extend and maintain long invasive pseudopods (Fig. 5 A), and 
invasive migration of cells into collagen I plugs was also sup-
pressed, with this effect greatest in the presence of both FN 
and cRGDfV (Fig. 5 B and Fig. S2D). Furthermore, IQGAP1 
depletion inhibited the invasive migration of MDA-MB-231 
and H1299-p53273H cells (which express mutant p53) but not 
in H1299 cells null for p53 (Fig. S2, E–H), indicating that 
IQGAP1 is required for RCP–51-driven pseudopod exten-
sion and invasion in FN-rich matrix.
Stable expression of RacGAP1 had no discernible effect 
on the ability of A2780 cells to extend invasive pseudopods or 
invade plugs of collagen I/FN in response to cRGDfV (Fig. 5, 
C and D). Expression of FLAG-RacGAP249A had little effect on 
basal migration but prevented cRGDfV- or mutant p53-driven 
pseudopod extension and invasion into collagen/FN (Fig. 5, 
C and D; and Fig. S2 I). Conversely, stable expression of FLAG-
RacGAP1249D promoted pseudopod extension and significantly 
increased invasion into FN-rich collagen even in the absence of 
cRGDfV (Fig. 5, C and D), and this was dependent on expres-
sion of IQGAP1 (Fig. 5 E and Fig. S2 J). Collectively, these data 
indicate that phosphorylation of RacGAP1 on T249 by PKB/Akt 
is an essential step in the acquisition of a migratory phenotype in 
cells invading FN-rich ECM and highlight the fundamental role 
of IQGAP1 as a scaffold for RacGAP1.
51 recycling suppresses Rac activity  
and promotes activation of RhoA
Inhibition of v3 promotes 51 recycling and downstream 
signaling via the RhoA effectors ROCK and cofilin to promote 
rapid, random migration on 2D substrates (White et al., 2007). 
Together with the identification of RacGAP1 as a Rac inactiva-
tor required for 51-driven invasive migration, this led us to 
hypothesize that 51 may not use the canonical Rac-driven cyto-
skeletal machinery to promote elongated invasive migration.
Using Raichu-Rac and -RhoA FRET probes (Itoh et al., 
2002; Yoshizaki et al., 2003), we analyzed the dynamic activ-
ity of Rac and RhoA in live cells migrating in 3D matrix by 
FRET–fluorescence lifetime imaging microscopy (FLIM). For both 
probes, the dynamic range was ascertained using dominant-negative 
or constitutively active probe mutants, and these membrane- 
targeted probes were distributed around the cell periphery with-
out concentrating at the front, similar to the intact GTPases 
(Fig. S1 A and Fig. S3 A). FLIM measurements were made by 
creating regions of interest (ROIs) around the plasma membrane 
at the front, middle, and rear of the cell (Fig. S3 B). Under basal 
conditions, high FRET efficiency indicated that Rac was acti-
vated toward the cell front, and this high Rac activity was main-
tained as cells migrated (Fig. 6, A, C, and D). However, upon 
treatment with cRGDfV, FRET efficiency was significantly re-
duced at the cell front but not in other regions (Fig. 6, B–D), 
indicating that Rac activity was suppressed at the tips of extend-
ing pseudopods. Low FRET efficiency revealed a low level of 
RhoA activity toward the cell front as cells migrated under basal 
conditions (Fig. 6, E, G, and H); stimulation of 51 recycling, 
however, promoted RhoA activity within the tips of pseudopods 
(Fig. 6, F–H). Again, the switch in RhoGTPase activity was more 
complex formation (Fig. 3 D). cRGDfV treatment also stimu-
lated the recruitment of FLAG-RacGAP1WT to IQGAP1 but 
not RacGAP1249A (Fig. 3, E and F), and RacGAP1249D showed 
an increased level of association with IQGAP1 even in the 
absence of cRGDfV (Fig. 3, E and F). In addition, proxim-
ity ligation assays (PLAs) revealed close association between 
IQGAP1 and RacGAP1 in cRGDfV-treated cells express-
ing RacGAP1WT; however, very little signal was detectable 
in cells expressing GFP or FLAG-RacGAP1249A (Fig. 3 G). 
Together, these data indicate that PKB/Akt phosphorylation 
of RacGAP1 on T249 promotes recruitment of RacGAP1 to 
IQGAP1-containing complexes.
IQGAP1 recruits phosphorylated  
RacGAP1 to the tips of protrusions  
as cells migrate in 3D
RacGAP1 plays a well-documented role in cytokinesis and lo-
calizes to the central spindle and midbody in mammalian cells 
(Lekomtsev et al., 2012). RacGAP1 is also expressed in inter-
phase cells and plays roles in nuclear transport of a Rac/Signal 
Transducer and Activator of Transcription module and main-
taining RhoA signaling at cell–cell junctions (Kawashima et al., 
2009, 2006; Ratheesh et al., 2012). Endogenous RacGAP1 is 
localized to the nucleus but also appears in a granular distribu-
tion in the cytoplasm (Fig. 4 A), and in cells migrating on CDM, 
RacGAP1 accumulates at the cell rear but appears to be ex-
cluded from the cell front (Fig. 4 A). After treatment with 
cRGDfV, the levels of RacGAP1 were increased within pseudo-
pods toward the cell front (Fig. 4 A). Knockdown of IQGAP1 
(Fig. S2 A) had relatively little influence on the localization of 
RacGAP1 under basal conditions (Fig. 4 B); however, in 
cRGDfV-treated IQGAP1 knockdown cells, RacGAP1 was ex-
cluded from the cell front (Fig. 4 B).
Stable overexpression of RacGAP1 resulted in an increase 
in the nuclear pool of RacGAP1 (Fig. 4 C). FLAG-RacGAP1WT 
predominantly localized to the nucleus in unstimulated cells but 
was recruited to the tips of invasive pseudopods upon treatment 
with cRGDfV. Here, RacGAP1 colocalized with IQGAP1 within 
structures that resemble filopodia (Fig. 4 C). RacGAP1249A did 
not localize to the cell front in cRGDfV-stimulated cells and 
was found to be predominantly in the nucleus (Fig. 4 C). Con-
versely, FLAG-RacGAP1249D was found in the nucleus and 
cytoplasm but was recruited to pseudopod tips even under basal 
conditions (Fig. 4 C). Together, these data indicate that phos-
phorylation of RacGAP1 on T249 promotes its recruitment to 
the front of invasive cells through association with IQGAP1.
The RacGAP1–IQGAP1 complex drives 
pseudopod extension and invasive migration
As phosphorylation of RacGAP1 downstream of RCP-51 
trafficking determines its association with IQGAP1 and sub-
cellular localization, we hypothesized that formation of the 
RacGAP1–IQGAP1 complex was required for RCP–51-
driven invasion. Knockdown of IQGAP1 had a profound influ-
ence on cell migration: cells plated on CDM displayed multiple 
protrusions, and the speed and persistence of migration were 
reduced in both the presence and absence of cRGDfV (Fig. 5 A 
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Figure 4. IQGAP1 recruits RacGAP1 to the tips of invasive pseudopods as cells migrate in 3D. (A and B) A2780 cells were subjected to control or IQGAP1 
#1 RNAi and seeded onto CDMs. Cells were stimulated with cRGDfV as indicated for 2 h before fixing and staining with rabbit anti-RacGAP1/anti– 
rabbit Cy2 antibodies and phalloidin–Texas red. (C) A2780 cells stably expressing GFP, FLAG-RacGAP1WT, FLAG-RacGAP1249A, or FLAG-RacGAP1249D 
on CDMs were stimulated with cRGDfV as indicated and fixed and stained with rabbit anti-IQGAP1/anti–rabbit Cy2 and mouse anti-FLAG/anti–mouse 
Cy3 antibodies. Images were captured using a spinning-disk confocal microscope, and representative pseudocolored images are shown. Zoomed insets 
correspond to areas indicated by dotted ROIs. Bars, 10 µm. Yellow arrows indicate direction of migration.
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Figure 5. The RacGAP1–IQGAP1 complex promotes integrin-dependent invasive migration. (A) A2780 cells were subjected to control or IQGAP1 #1 
RNAi and seeded onto CDMs. Images were captured, and pseudopod length was determined as in Fig. 2 (A and B; n > 100/condition). (B) A2780 
cells were treated as in A and seeded into inverted invasion assays in the presence or absence of FN and cRGDfV as indicated. (C) A2780 cells stably 
expressing GFP, RacGAP1WT, RacGAP1249A, or RacGAP1249D were seeded onto CDMs and stimulated with cRGDfV as indicated, images were captured, 
and pseudopod length was measured as in Fig. 2 (A and B; n > 40/condition). (D) A2780 cells as in C were seeded into inverted invasion assays in the 
presence of FN and stimulated with cRGDfV as indicated. (E) A2780 cells stably expressing GFP, RacGAP1WT, or RacGAP1249D were transfected as in A 
and seeded into inverted invasion assays in the presence of FN and cRGDfV. Yellow lines indicate the level of invasion or pseudopod length under control 
conditions. Bars, 50 µm. Data represent means ± SEM from at least three independent experiments. *, P < 0.05; ***, P < 0.001.
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Figure 6. Integrin trafficking suppresses Rac activity and activates RhoA. (A and B) A2780 cells expressing Raichu-Rac were seeded onto CDMs 
and stimulated with cRGDfV as indicated. Fluorescence lifetime images were captured at 1-min intervals, and representative lifetime maps are shown. 
(C) FRET efficiency was calculated for ROIs at the cell periphery at the front, middle (mean of the two sides), or back, from lifetime maps generated 
as in A and B (single images or means of all frames from time-lapse videos, n > 30/condition). (D) FRET efficiency at the cell front was calculated as 
in C (for each frame of time-lapse videos, n > 9/condition). (E and F) A2780 cells expressing Raichu-RhoA were analyzed as in A and B. (G) FRET 
efficiency was calculated as in C (n > 35/condition). (H) FRET efficiency at the cell front was calculated as in D (n > 15/condition). (I) H1299 cells 
stably expressing mutant p53 (273H) or control vector (VEC) were transfected with Raichu-Rac or Raichu-RhoA. FLIM was performed as in A and B, 
and FRET efficiency at the cell front was calculated as in C (n > 8/condition). (J) A2780 cells were transfected with control or RCP-specific siRNA and 
allowed to recover for 24 h. Cells were then transfected with Raichu-Rac or Raichu-RhoA. FLIM was performed as in A and B, and FRET efficiency at 
the cell front was calculated as in C (n > 13/condition). (K) A2780 cells expressing Raichu-RhoA were seeded onto CDMs and treated with vehicle or 
the Rac inhibitor NSC-23766 for 2 h. FLIM was performed as in A and B, and FRET efficiency at the cell front was calculated as in C (control, n = 8; 
NSC-23766, n = 10). Yellow lines represent the baseline activity as determined by an inactive mutant of the probe. Data represent means ± SEM from 
at least three independent experiments. *, P < 0.05; **, P < 0.01; ***, P < 0.001. Zoomed images from videos are shown in the time sequence and 
correspond to areas indicated by dotted ROIs. Bars, 10 µm.
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the requirement for these RhoGTPases in 3D migration within 
FN-rich ECM. Rac1 knockdown had little influence on the 
extension of invasive pseudopods or speed and persistence of 
migration on CDM in the presence of cRGDfV (Fig. 8 A and 
Fig. S4, A and E–G), indicating that RCP–51-driven pseu-
dopodial migration is Rac independent. However, the migration 
of Rac1 knockdown cells under basal conditions was character-
ized by extension of long invasive pseudopods in the direction 
of migration, and this effect was reversed by expression of an 
siRNA-resistant GFP-Rac1 (Fig. 8, A and B; and Fig. S4 H). 
Similar results were obtained using a chemical inhibitor of Rac 
activation (Fig. S4, I–K). Furthermore, although invasion of 
cRGDfV-treated or mutant p53-expressing cells into FN-rich 
collagen plugs was largely unaffected by knockdown of Rac1, 
Rac1 depletion promoted a striking increase in invasion in the 
absence of these RCP–51-promoting factors (Fig. 8, E–G). 
These data indicate that Rac1 activation is not required for 
51-driven invasive migration and that suppression of Rac1 
levels, or Rac1 inactivation, is sufficient to drive pseudopodial 
invasion into FN-rich ECM.
RhoA is required for 51-driven invasion
RhoA-depleted cells were unable to extend and maintain long 
pseudopodial projections in the presence of cRGDfV (Fig. 8 A) 
and showed reduced speed and persistence migration in CDMs 
regardless of stimulation, and this was rescued by expression of 
siRNA-resistant GFP-RhoA (Fig. 8, C and D; and Fig. S4, E, F, 
and H). Furthermore, RhoA knockdown abrogated cRGDfV- or 
mutant p53-stimulated invasion into FN-rich collagen (Fig. 8, 
E–G). These data demonstrate that RhoA is required for RCP–
51-driven invasion.
RCP-dependent 51 trafficking promotes 
formation of F-actin–rich spikes and cell 
elongation in FN-rich collagen gels
The migration of cells with an elongated morphology in 3D has 
been categorized as mesenchymal, dependent on Rac/Cdc42, 
and distinct from amoeboid (RhoA driven) migration (Sahai, 
2007; Friedl and Alexander, 2011). However, here, we have de-
scribed movement of elongated cells within 3D matrix that is 
independent of Rac but dependent on RhoA. We therefore char-
acterized the morphology and actin dynamics of cells migrating 
with RCP–51-driven pseudopodia.
Mesenchymally migrating HT1080 cells (Wolf et al., 2003) 
display a morphology on CDM that is consistent with high Rac 
activity, with numerous wavelike dynamic protrusions, resem-
bling small lamellipodia (Fig. 9 A). A2780 cells migrating in 3D 
under basal conditions also display wavelike protrusions at the 
leading edge, consistent with high Rac activity, but these protru-
sions appear less dynamic and smaller than those observed in 
HT1080 cells (Fig. 9 A). Strikingly, cRGDfV treatment drasti-
cally changed the morphology of cells, triggering the formation 
of numerous short, dense, and linear F-actin spikes that appear at 
the cell front and precede forward movement (Fig. 9, A and B).
In CDM, RCP-dependent 51 trafficking promotes elon-
gation and extension of pseudopodial processes in the direction 
of migration (Fig. 1 A; Caswell et al., 2008; Rainero et al., 2012). 
pronounced within peripheral regions at the cell front, and this 
level of RhoA activity was maintained as cells migrated (Fig. 6, 
G and H). Expression of mutant p53 also suppressed Rac activ-
ity and promoted activation of RhoA at the front of cells migrat-
ing on CDM (Fig. 6 I), indicating that this RhoGTPase switch 
is a general feature of cells that use the RCP–51 machinery 
for motility in 3D.
RCP is the Rab11 effector that controls the recycling of 51 
and associated RTKs in invasive cancer cells (Caswell et al., 2008; 
Muller et al., 2009). Although knockdown of RCP had little effect 
on the balance between Rac and RhoA activity under basal condi-
tions, RCP knockdown cells were unable to respond to cRGDfV 
and switch RhoGTPase activity (Fig. 6 J and Fig. S3 C). This is 
consistent with the inability of RCP knockdown cells to extend 
pseudopodial extensions and invade FN-rich 3D matrix (Caswell 
et al., 2008; Rainero et al., 2012) and indicated a requirement for 
RCP-dependent trafficking in the RhoGTPase switch.
Because the activities of Rac and RhoA are reciprocally 
related (Guilluy et al., 2011), we tested whether suppression 
of Rac activity alone influenced RhoA. Treatment with a small 
molecule inhibitor of Rac, NSC-23766, promoted an increase in 
activity of RhoA at the front of cells moving on CDM (Fig. 6 K), 
indicating that suppressing Rac activity is sufficient to permit 
RhoA activation at the cell front.
The RacGAP1–IQGAP1 complex 
suppresses Rac activity and promotes 
activation of RhoA
Biochemical experiments revealed that FLAG-RacGAP1 im-
munoprecipitated from A2780 cells could directly promote 
GTPase activity of recombinant Rac but not Ras (Fig. S3 D). 
Furthermore, although RacGAP1 knockdown had little influ-
ence on the activities of Rac and RhoA in cells migrating on 
CDM under basal conditions, RacGAP1 knockdown cells were 
unable to switch RhoGTPase activity when treated with cRGDfV 
(Fig. 7 A). Similarly, IQGAP1 knockdown had relatively little 
influence on RhoGTPase activity under basal conditions but 
prevented inactivation of Rac and activation of RhoA at the cell 
front when cells were stimulated with cRGDfV (Fig. 7 B).
As RacGAP1–IQGAP1 association is regulated by phos-
phorylation on T249, we sought to determine the requirement 
for RacGAP1 phosphorylation in the RhoGTPase switch. FLAG-
RacGAP1249A was unable to support the suppression of Rac 
activity and activation of RhoA at the cell front in cells stimu-
lated with cRGDfV (Fig. 7, C and D). Conversely, expression of 
FLAG-RacGAP1249D, which is recruited to IQGAP1 and the 
cell front under basal conditions, was sufficient to suppress Rac 
and promote RhoA activity in cells migrating on CDM (Fig. 7, 
C and D). Collectively, these data suggest that the formation of 
the RacGAP1–IQGAP1 complex drives the localized suppres-
sion of Rac activity and concomitant activation of RhoA as cells 
migrate within FN-rich matrices.
Suppression of Rac drives invasion  
into FN-rich ECM
Given that the RacGAP1–IQGAP1 complex suppressed Rac 
and activated RhoA at the front of invasive cells, we determined 
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Figure 7. Integrin trafficking suppresses Rac activity and activates RhoA through the RacGAP1–IQGAP1 complex. (A) A2780 cells were subjected to 
control or RacGAP1 oligo #6 RNAi and allowed to recover for 24 h. Cells were then transfected with Raichu-Rac or Raichu-RhoA as indicated and 
seeded onto CDM. FLIM was performed, and FRET efficiency at the cell front was calculated as in Fig. 6 (A–C; n ≥ 15/condition). (B) A2780 cells were 
subjected to control or IQGAP1 oligo #1 RNAi and allowed to recover for 24 h. Cells were then transfected with Raichu-Rac or Raichu-RhoA as indicated 
and seeded onto the CDM. FLIM was performed, and FRET efficiency at the cell front was calculated as in Fig. 6 (A–C; n ≥ 8/condition). (C) A2780 
cells stably expressing RacGAP1WT, RacGAP1249A, or RacGAP1249D were transfected with Raichu-Rac and seeded onto CDMs. FLIM was performed, and 
FRET efficiency at the cell front was calculated as in Fig. 6 (A–C). Representative images are shown (n ≥ 8/condition). (D) A2780 cells stably expressing 
RacGAP1WT, RacGAP1249A, or RacGAP1249D were transfected with Raichu-RhoA and seeded onto CDMs. FLIM was performed, and FRET efficiency at the 
cell front was calculated as in Fig. 6 (A–C). Representative images are shown (n ≥ 4/condition). Zoomed insets correspond to areas indicated by dot-
ted ROIs. Yellow lines represent the baseline activity as determined by an inactive mutant of the probe. Data represent means ± SEM from at least three 
independent experiments. *, P < 0.5; ***, P < 0.001. Bars, 10 µm.
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previously classified mesenchymal and amoeboid migration in 
3D matrix and is characterized by the extension of long pseudo-
podial processes tipped by linear arrays of actin spikes.
Discussion
Here, we determine the mechanism through which RCP-driven 
51 recycling promotes invasive migration into FN-rich 
ECM. PKB/Akt is locally activated within the pseudopod tip as 
In FN-rich collagen gels, under basal conditions, the morphol-
ogy of A2780 cells was restricted by the dense fibrillar network, 
and cells remained relatively rounded and displayed short pro-
jections (Fig. 9 C). In the presence of cRGDfV, the morphology 
of cells changed drastically, and cells became less spherical and 
more elongated, with long, thick actin-rich protrusions formed, 
reminiscent of pseudopods observed in CDM (Fig. 9, C–E). Col-
lectively, these data suggest that the RCP–51 pathway pro-
motes a mode of elongated migration that is distinct from 
Figure 8. Integrin trafficking promotes inva-
sive migration through the suppression of Rac 
activity and activation of RhoA. (A) A2780 
cells were subjected to control, Rac1, or RhoA 
SMARTpool RNAi and seeded onto CDMs 
after 24–36 h. Cells were stimulated with 
cRGDfV as indicated, and images were cap-
tured as in Fig. 2 A. Representative images are 
shown. Bar, 50 µm. (B–D) A2780 cells were 
cotransfected with GFP-Rac1 or GFP-RhoA 
(as indicated) alongside control, Rac1 #1, or 
RhoA #1 RNAi oligos and seeded onto CDM 
as in A, and images were captured as in 
Fig. 2 A. (B) Pseudopod length (>30 cells/con-
dition) was measured as in Fig. 2 A. (C and D) 
Speed and persistence (≥26 cells/condition) 
of migration was analyzed using ImageJ. 
(E) A2780 cells were subjected to control, 
Rac1, or RhoA SMARTpool RNAi and seeded 
into inverted invasion assays in the presence of 
FN and cRGDfV. (F and G) MDA-MB-231 (F) or 
H1299-vector (VEC)/273H cells were subjected 
to control, Rac1, or RhoA SMARTpool RNAi and 
seeded into inverted invasion assays in the pres-
ence of FN. Data represent means ± SEM from 
at least three independent experiments. *, P < 
0.05; **, P < 0.01; ***, P < 0.001.
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Figure 9. RCP-dependent 51 trafficking promotes formation of actin spikes at the cell front and elongated movement in 3D matrix. (A) HT1080 and 
A2780 cells expressing Lifeact-mEGFP were plated onto CDM for 4 h before imaging. Actin dynamics were captured as cells move in 3D using a spinning-
disk confocal microscope. Arrows indicate dynamic protrusions. Zoomed images from videos are shown in the time sequence and correspond to areas 
indicated by dotted ROIs. Bars, 20 µm. (B) Normalized actin density at protrusions was calculated by dividing the mean integrated density at protrusions 
by the mean integrated density within the whole cell (n > 500/condition). (C) A2780 cells were allowed to invade through a plug of collagen and FN 
for 24 h before fixation. Cells were stained for actin and imaged top to bottom using a confocal microscope. Maximum projections were produced using 
ImageJ, and the 3D reconstructions were made using Imaris. Bars, 50 µm. (D) The 2D shape descriptors were calculated from the maximum projections 
images, using the particle analysis plug-in of ImageJ (n > 46/condition). (E) The 3D shape descriptors were calculated from the entire cell volume, using 
the 3D shape plug-in of ImageJ (n > 46). Data represent means ± SEM from at least three independent experiments. ***, P > 0.01.
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assays. We demonstrate that RCP–51-driven invasive migra-
tion is further distinguished by morphology and RhoGTPase re-
quirement: it is characterized by extension of long pseudopodial 
protrusions driven by RhoA (Fig. 8, A–C) and antagonized by 
Rac1 (Fig. 8, A–C). Furthermore, RCP–51 induces the forma-
tion of short linear arrays of actin spikes at the leading edge, which 
appear to drive protrusion in 3D matrix (Fig. 9 A), rather than 
wavelike lamellipodia. We have noted that ROCK activity is dis-
pensable for protrusion and is only required for retraction of the 
cell rear (unpublished data), leading us to speculate that cytoskeletal 
reorganization could be driven by other classes of RhoA effectors. 
Formin homologous domain proteins are capable of generating 
spikelike F-actin structures by polymerizing actin from the barbed 
end, and members of this family play important roles in cancer cell 
invasion (Brandt et al., 2009; Kitzing et al., 2010; Vega et al., 2011).
RhoGTPases are major downstream effectors of integrins 
and are required for many of the myriad functions of this family 
of adhesion receptors, in particular those relating to cell migration 
(Ridley et al., 2003). In fibroblasts, v3 (and v3 recycling) 
promotes persistent lamellipodial migration in 2D through Rac, 
whereas 51 (and 51 recycling) signals via RhoA/ROCK to 
favor rapid, random migration (Danen et al., 2005; White et al., 
2007; Morgan et al., 2013). The reciprocity of these phenotypes is 
reflected in the plasticity of carcinoma cells as they invade: v3 
recycling promotes invasion into 3D matrix in the absence of FN, 
whereas 51 recycling promotes invasion into FN-rich ECM 
(Caswell et al., 2008; Muller et al., 2009; Christoforides et al., 
2012; Rainero et al., 2012; Jacquemet et al., 2013a). DGK-– 
dependent production of PA recruits RCP to the tips of invasive 
pseudopods via a C2 domain and restricts the localization of 51 
recycling vesicles (Rainero et al., 2012). Thus, the RCP–51 
pathway encodes spatial information, which is transduced via 
PKB/Akt to the RacGAP1–IQGAP1 complex, to locally suppress 
Rac1 activity and activate RhoA at the cell front. Although Rac-
GAP1 can directly inactivate Rac1, the mechanism through which 
RhoA is activated remains unclear. Chemical inhibition of Rac is 
sufficient to promote RhoA activity at the cell front (Fig. 6 K), 
consistent with the findings of others (Guilluy et al., 2011), and 
also to promote pseudopod extension (Fig. S4 I). This suggests 
that suppression of Rac is a key event that promotes RhoA activ-
ity and initiates pseudopod extension. Although RacGAP1 phos-
phorylation does not influence binding of RacGAP1 to the RhoA 
GEF Ect2 (Fig. 3 C), it is possible that RacGAP1 localizes the 
activity of this RhoA GEF in migrating cells as is the case at 
adherens junctions in epithelial cells (Ratheesh et al., 2012).
Our findings indicate that RCP regulates 51 trafficking 
to sustain localized signaling to RhoGTPases. Phosphorylation 
of RacGAP1 by PKB/Akt, as a consequence of integrin-medi-
ated EGFR1 trafficking and signaling, promotes recruitment to 
the front of invading cells via IQGAP1. This leads to suppression 
of Rac activity, which is sufficient to promote pseudopod exten-
sion and invasion by permitting activation of RhoA. FN is key to 
RCP–51-driven invasion, indicating that the extracellular en-
vironment is a critical determinant of the mode of migration and 
RhoGTPase requirement of cells migrating in 3D, highlighting 
the importance of both intrinsic and extrinsic factors in determin-
ing the metastatic dissemination of tumor cells.
a consequence of RCP–51 trafficking and phosphorylates Rac-
GAP1, a Rac- and Cdc42-specific GAP, on T249. This promotes 
recruitment of RacGAP1 to IQGAP1 within the tips of invasive 
pseudopods as cells migrate in 3D and provides the platform for 
local suppression of Rac1 activity and activation of RhoA to drive 
protrusion and invasion in FN-rich 3D matrix (Fig. 10).
Although IQGAP1 can both positively and negatively 
regulate small GTPase activity, it possesses no intrinsic GAP or 
GEF activity. IQGAP1 can bind directly to active RhoGTPases, 
e.g., Cdc42, prolonging their activity (Ho et al., 1999, Brown 
and Sacks, 2006). However, in spreading fibroblasts, IQGAP1 is 
recruited to sites of integrin activation and recruits RacGAP1 to 
suppress Rac1 (Jacquemet et al., 2013b). We now show that the 
phosphorylation-dependent recruitment of RacGAP1 to IQGAP1 
at the front of invading cells suppresses Rac1 activity (Fig. 6 and 
Fig. 7) and is central to the mechanism through which RCP–51 
controls cancer cell invasion. A large body of evidence has sug-
gested that IQGAP1 plays a role in tumorigenesis and invasive 
migration (Mataraza et al., 2003; Johnson et al., 2009; Jameson 
et al., 2013). Consistent with this, we found that IQGAP1 knock-
down inhibits invasive migration (Fig. 5, A and B; and Fig. S2, 
D–F). RacGAP1 expression is also associated with tumorigenesis 
(Lu et al., 2004; Wang et al., 2011), and we provide evidence here 
that RacGAP1 requires IQGAP1 to facilitate invasive migration 
(Fig. 5, C–E). Further studies will reveal whether cooperation and 
simultaneous up-regulation of RacGAP1 and IQGAP1 is a fea-
ture of human cancers, in particular those that express mutant p53 
or soluble v3 ligands such as osteopontin.
We have shown a novel function of RacGAP1 in invasive 
migration. The PKB/Akt phosphorylation site within RacGAP1, 
T249, is not within any recognizable structural region (Fig. S1 E) 
and is therefore unlikely to directly influence GAP activity as re-
ported for Aurora kinase (Minoshima et al., 2003). Furthermore, 
T249 is outside of the regions known to interact with MKLP1, 
Ect2, or Rab11-FIP3 (Mishima et al., 2002; Yüce et al., 2005; 
Simon et al., 2008), and phosphorylation at T249 did not influ-
ence binding of MKLP1 or Ect2 (Fig. 3 C) or the rate of prolif-
eration of cancer cells (Fig. S1 K). These observations suggest 
that PKB/Akt phosphorylation does not regulate cytokinesis and 
instead plays a role in the recruitment of RacGAP1 to IQGAP1 
at the cell periphery during invasive migration.
Rac and RhoA control different modes of migration, and 
plasticity exists within migratory systems to allow switching be-
tween modes (Sahai, 2007; Sanz-Moreno et al., 2008; Friedl and 
Alexander, 2011; Deakin and Turner, 2011). Mesenchymal mi-
gration is thought to be adhesion dependent, and amoeboid migra-
tion is less so (Friedl and Alexander, 2011), although amoeboid 
tumor cells can form adhesions (Deakin and Turner, 2011; 
Poincloux et al., 2011). More recently, lobopodial migration has 
been described in matrices exhibiting linear elasticity, including 
CDMs and dermal explants, and this requires integrin adhesion 
formation and RhoA-ROCK (Petrie et al., 2012). Our evidence 
indicates that RCP–51-driven invasive migration is distinct 
from previously described modes of migration, first in the require-
ment for the ECM component FN, which is important in metastatic 
progression (Psaila and Lyden, 2009; Reticker-Flynn et al., 2012; 
Ghajar et al., 2013), but not present in many in vitro invasion 
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Figure 10. RCP-dependent 51 recycling regulates the localization of RacGAP1 and downstream signaling to RhoGTPases. (A) 51 trafficking is sup-
pressed by v3 or the transcriptional activity of p63, and Rac signaling predominates at the leading edge. (B) Inhibition of v3 or expression of gain-
of-function mutant p53 promotes the association of RCP with 51, recruitment of EGFR1, and subsequent recycling. Production of PA by DGK- within 
the tips of pseudopods recruits RCP–51/EGFR1 vesicles and localizes downstream signaling via PKB/Akt. Here, PKB/Akt phosphorylates RacGAP1, 
allowing its recruitment to IQGAP1, providing a platform for the inactivation of Rac and activation of RhoA to promote pseudopod extension and invasion 
in FN-rich ECM. P, phosphorylation.
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IP
For IPs, A2780 cells were serum starved overnight and stimulated with 
cRGDfV for 30 min and 30 ng/ml EGF for 5 min before lysis in the ap-
propriate buffer. For PKB/Akt substrate IPs, A2780 cells were lysed in 
lysis buffer (200 mM NaCl, 75 mM Tris-HCl, pH 7, 15 mM NaF, 1.5 mM 
Na3VO4, 7.5 mM EDTA, 7.5 mM EGTA, 1.5% [vol/vol] Triton X-100, 
0.75% [vol/vol] NP-40, 50 µg/ml leupeptin, 50 µg/ml aprotinin, and 1 mM 
AEBSF). Lysates were passed three times through a 27-gauge needle and 
clarified by centrifugation at 10,000 g for 10 min at 4°C. Magnetic 
beads conjugated to sheep anti–rabbit IgG (Invitrogen) were bound to 
anti-RXRXXS*/T*. Antibody-coated beads were incubated with lysates for 
2 h at 4°C with constant rotation. Unbound proteins were removed by ex-
tensive washing in lysis buffer, and specifically, associated proteins were 
eluted from the beads by boiling for 10 min in Laemmli sample buffer. 
Proteins were resolved by SDS-PAGE and analyzed by Western blotting or 
liquid chromatography–MS/MS.
For co-IPs, A2780 cells were lysed in CSK buffer (10 mM Pipes, 
pH 6.8, 150 mM NaCl, 150 mM sucrose, 3 mM MgCl2, 0.5% [vol/vol] 
Triton X-100, 10 µg/ml leupeptin, 10 µg/ml aprotinin, 0.5 mM AEBSF, and 
2 mM Na3VO4). Lysates were clarified (centrifugation at 10,000 g for 10 min 
at 4°C) and incubated with rabbit anti-IQGAP1 antibody-coated sheep 
anti–rabbit magnetic beads (Invitrogen) or mouse anti-FLAG antibody-coated 
sheep anti–mouse magnetic beads (Invitrogen) for 1–2 h at 4°C. Complexes 
bound to the beads were isolated using magnets, washed three times with 
ice-cold lysis buffer, and eluted in Laemmli reducing sample buffer. Proteins 
were resolved by SDS-PAGE and analyzed by Western blotting.
Lentiviral production and transduction
Lentiviruses were produced by transfecting 293T cells with three plasmids 
(psPAX2, pMD2.G, and pWPLX). Conditioned medium containing viruses 
was collected after 5 d and then used immediately to infect cells or stored 
at 80°C. Infection rate in A2780 and MDA-MB-231 cells was close to 
100%, and stable transfectants retained expression of RacGAP1 and mu-
tants over several months.
SDS-PAGE and quantitative Western blotting
Protein extracts were separated under denaturing conditions by SDS-PAGE 
(4–12% Bis-Tris gels; Invitrogen) and transferred to nitrocellulose mem-
brane. Membranes were blocked and incubated overnight at 4°C with the 
appropriate primary antibody and then at room temperature for 1 h with 
the appropriate fluorophore-conjugated secondary antibody. Membranes 
were scanned using an infrared imaging system (Odyssey; LI-COR Biosci-
ences). Band intensity was determined by digital densitometric analysis 
using Odyssey software (version 2.1). Blots shown are representative of at 
least three independent experiments.
MS data acquisition and analysis
MBP-RacGAP1 and RxRxxS/T pull-down samples were analyzed by liquid 
chromatography–MS/MS using a liquid chromatography system (nanoAC-
QUITY UltraPerformance; Waters) coupled online to a linear ion trap (LTQ 
Velos; Thermo Fisher Scientific). Peptides were separated on a bridged 
ethyl hybrid C18 analytical column (75 mm × 250 µm; 1.7 µm particle 
size; Waters) using a 45-min linear gradient from 1 to 25% (vol/vol) 
acetonitrile in 0.1% (vol/vol) formic acid at a flow rate of 200 nl/min. 
Peptides were selected for fragmentation automatically by data-dependent 
analysis. Tandem mass spectra were extracted using extract_msn (Thermo 
Fisher Scientific) executed in Mascot Daemon (version 2.2.2; Matrix Sci-
ence). Peak list files were searched against the International Protein Index 
human database (version 3.70; release date March 4, 2010) modified 
to contain 10 additional contaminants and reagent sequences of nonhu-
man origin. Searches were submitted to an in-house Mascot server (ver-
sion 2.2.03; Matrix Science; Perkins et al., 1999). Carbamidomethylation 
of cysteine was set as a fixed modification, and oxidation of methionine 
and phosphorylation of serines, threonines, and tyrosines were set as vari-
able modifications. Only tryptic peptides were considered, with up to one 
missed cleavage permitted. Monoisotopic precursor mass values were 
used, and only doubly and triply charged precursor ions were consid-
ered. Mass tolerances for precursor and fragment ions were 5 ppm and 
0.5 D, respectively. Data were further analyzed using the search engine 
X! Tandem (version 2007.01.01.1; Craig and Beavis, 2003) implemented 
from within Scaffold (version 3.00.03; Proteome Software). Data were vali-
dated in Scaffold using a threshold of identification of ≥90% probability 
at the peptide level, ≥99% probability at the protein level, and assignment 
of at least two unique, validated peptides. Identified proteins were hierar-
chically clustered on the basis of uncentered Pearson’s correlation using 
Materials and methods
Cell culture and transient transfection
A2780 cells were cultured in RPMI 1640 and H1299, and MDA-MB-231 
and HT1080 cells were cultured in DMEM (Sigma-Aldrich) supplemented 
with 10% FCS and grown at 37°C and 5% CO2. Transient transfections 
and knockdowns were performed using the nucleofector (A2780s; Solu-
tion T; 3 µg plasmid DNA or 1 µM siRNA; program A-23; Amaxa), Lipo-
fectamine 2000 for siRNA transfection (MDA-MB-231, H1299, and 
IQGAP1 siRNA; 100 nM siRNA; two rounds of transfection), or Lipo-
fectamine LTX (for A2780 and HT1080 mEGFP-Lifeact transfections) ac-
cording to the manufacturer’s instructions. CDMs were prepared as 
described previously (Cukierman et al., 2001; Caswell et al., 2008). In 
brief, tissue-culture plates were gelatin coated, cross-linked with glutaral-
dehyde, quenched, and equilibrated in DMEM containing 10% FCS. 
Human telomerase-immortalized fibroblasts were seeded at near conflu-
ence and grown for 8–10 d in DMEM containing 10% FCS and 50 µg/ml 
ascorbic acid. Matrices were denuded of living cells by incubation with 
PBS containing 20 mM NH4OH and 0.5% Triton X-100, and DNA residue 
was removed by incubation with DNase I.
Plasmids and reagents
RNAi oligonucleotides (oligo) were purchased from Thermo Fisher Scientific 
as follows: ON-TARGETplus nontargeting siRNA (single oligo or pool as ap-
propriate); IQGAP1 #1 (5-GAACGUGGCUUAUGAGUAC-3); IQGAP1 
#2 (J-004694-08); RacGAP1 (SMARTpool, oligo 6, 5-GCGAAGUGCU-
CUGGAUGUU-3; and oligo 8, 5-GAAGUCACAUCUGCCUGUU-3); 
Rac1 (SMARTpool or Rac1 #1, 5-CGGCACCACUGUCCCAACA-3); 
RhoA (SMARTpool or RhoA #1, 5-AUGGAAAGCAGGUAGAGUU-3); and 
RCP (J-015968-10). shRNA vectors for PKB/Akt isoforms were pre-
pared using mU6Pro and the following sequences: Akt1 #1, 5-GCTA-
CTTCCTCCTCAAGAA-3; Akt1 #2, 5-CGAGTTTGAGTACCTGAAG-3; 
Akt2 #1, 5-CGTGGTGAATACATCAAGA-3; and Akt2# 2, 5-TCTGTCAT-
CAAAGAAGGCT-3. Mammalian expression vectors encoding siRNA- 
resistant GFP-Rac1 (pEGFP-C2, full length, and resistant to Rac1 #1) and 
GFP-RhoA (pcDNA-DEST53, full length, and resistant to RhoA #1) were 
gifts from A. Ridley (King’s College London, London, England, UK; Vega 
et al., 2011; Reymond et al., 2012). Akind, Raichu-Rac (Raichu-1011X), 
and Raichu-RhoA (Raichu-1237X) in the pCAGGS backbone were gifts from 
M. Matsuda (Kyoto University, Kyoto, Japan; Itoh et al., 2002; Yoshizaki 
et al., 2003, 2007). Bacterial expression vector pMAL encoding MBP-
RacGAP1 was a gift from T. Kitamura (Tokyo University, Tokyo, Japan). A 
codon-optimized RacGAP1-FLAG was synthesized by GenScript and cloned 
into the lentiviral vector pWPLX using BamHI and EcoRI (Addgene). Point 
mutations were introduced using site-directed mutagenesis (QuikChange 
Lightning; Agilent Technologies). For MBP-RacGAP1 the following primers 
were used: T249A, 5-GACCAGGAGCCGAAGGAAAGCAGGTACTTTA-
CAAC-3; and T251A, 5-GCCGAAGGAAAACAGGTGCTTTACAACCTT-
GGAAC-3. For codon-optimized RacGAP1-FLAG the following primers 
were used: T249A, 5-AGCCGGCGGAAGGCAGGCACTCTGC-3; and 
T249D, 5-CGGAGCCGGCGGAAGGACGGCACTCTGCAGCCC-3. 
Rac inhibitor NSC-23766 was purchased from EMD Millipore and used 
at a concentration of 25 µM. cRGDfV was purchased from Bachem and 
added directly to the culture medium at a concentration of 2.5 µM. The 
broad specificity kinase inhibitor staurosporine was purchased from EMD 
Millipore and used at a concentration of 10 µM.
Rabbit anti-IQGAP1 (H-109), rabbit anti-RacGAP1 (B-7), rabbit 
anti-MKLP1 (N-19), rabbit anti-RhoA (119), and mouse anti–PKB-/Akt2 
(F-7) were purchased from Santa Cruz Biotechnology, Inc. Mouse anti-
RacGAP1 (1G6), mouse anti-FLAG (M2), mouse anti–-tubulin, and mouse 
anti–-actin were purchased from Sigma-Aldrich. Mouse anti-Rac1 (23A8) 
was purchased from EMD Millipore. Rabbit anti-RxRxxS*/T* (110B7E) 
and rabbit anti–PKB-/Akt1 (C73H10) were purchased from Cell Signal-
ing Technology. Rabbit anti-Ect2 (raised against Ect2 aa 1–421) was a 
gift from M. Petronczki (London Research Institute, London, England, UK; 
Su et al., 2011).
In vitro kinase assay
MBP-RacGAP1 and mutants were produced in BL-21 strain Escherichia 
coli and purified using Amylose resin (New England Biolabs, Inc.). 18 µg 
MBP-RacGAP1 was incubated with recombinant active PKB-/Akt2 (PH/
S474D; 0.5 µg of 0.155 U; EMD Millipore) and 10 mM ATP (including 
10 µCi -[33P]ATP) in reaction buffer (100 mM Tris, pH 7.5, 10 mM MgCl2, 
30 mM -mercaptoethanol, and 20% glycerol). Reactions were terminated 
by addition of reducing sample buffer.
933Local Rac suppression promotes pseudopod extension • Jacquemet et al.
in inserts (Transwell; Corning) for 1 h at 37°C. Inserts were then inverted, 
and cells were seeded directly onto the opposite face of the filter. Transwell 
inserts were finally placed in 0.1% serum medium, and medium supple-
mented with 10% FCS and 30 ng/ml EGF was placed on top of the matrix, 
providing a chemotactic gradient. Where appropriate, 2.5 µM cRGDfV was 
added to the matrix before plug polymerization and also to the medium 
throughout the system. 48–72 h after seeding, migrating cells were visual-
ized with Calcein-AM and visualized by confocal microscopy with serial op-
tical sections being captured at 15-µm intervals using a confocal microscope 
(SP2; Leica) and a 20× objective lens. Individual confocal images are pre-
sented in sequence with increasing penetrance from left to right. Invasion 
was quantified using the area calculator plugin in ImageJ, measuring the fluor-
escence intensity of cells invading 45 µm or more and expressing this as a 
percentage of the fluorescence intensity of all cells within the plug.
PLA
PLAs were performed according to the manufacturer’s instructions (Duo-
link) using the Duolink In Situ PLA probe anti–Rabbit PLUS and anti–Mouse 
MINUS and the Duolink In Situ Detection Reagents Red (Sigma-Aldrich). 
Cells were counterstained using FITC-phalloidin (Invitrogen) and imaged 
using a spinning-disk confocal microscope (Marianas) using a 100× objec-
tive lens, and images were analyzed using ImageJ.
GAP assay
GAPs assays were performed using a RhoGAP assay kit (Cytoskeleton, 
Inc.) in a similar manner to Bastos et al. (2012). In brief, two 15-cm plates 
(A2780-GFP or A2780-FLAG-RacGAP1WT) were lysed per GAP assay con-
dition and immunoprecipitated with anti-FLAG antibodies. Immunoprecipi-
tates were washed copiously with final washes in TBS. GTP was added to 
mixtures of immunoprecipitate, and GTPase was added for 30 min at 
37°C before incubation with CytoPhos reagent and measurement of opti-
cal density at 650 nm.
Proliferation assay
Cells were seeded at 5,000 cells per well in 96-well plates. Cell number 
was assayed at varying time points over 7 d using CellTiter 96 kit (Pro-
mega). In brief, cells were seeded into 96-well plates and allowed to pro-
liferate for ≤7 d. Dye solution was added to each well, and the plate was 
returned to 37°C for 4 h before addition of stop solution. The plate was 
incubated at room temperature overnight, and absorbance was read at 
570 nm. Cell number was normalized to the number of cells (absorbance 
at 570 nm) 16 h after seeding (day 0).
Statistical analysis
Statistical analyses were performed as appropriate, and p-values are indi-
cated by asterisks in the figure legends. Z tests were performed where 
n > 30; in all other cases, the Student’s t test was used (unpaired, two 
tailed, and unequal variance).
Online supplemental material
Fig. S1 shows that Akt2 and RacGAP1 are required for RCP–51-driven 
invasion. Fig. S2 shows that IQGAP1 is required for migration on CDM and 
invasion into collagen/FN matrix. Fig. S3 shows localization of Raichu-Rac 
and -RhoA and GAP activity of RacGAP1 in A2780 cells. Fig. S4 shows 
that Rac and RhoA differentially regulate migration on CDM. Video 1 shows 
FLAG-RacGAP1WT–expressing cells migrating in the presence and absence 
of cRGDfV, the inhibition of pseudopod extension by expression of FLAG-
RacGAP1249A, and the adoption of pseudopodial migration by cells expressing 
FLAG-RacGAP1249D. Videos 2–5 show the activities of Raichu-Rac and -RhoA 
in cells ± cRGDfV. Video 6 shows the effect of Rac and RhoA knockdown on 
migration on CDM. Video 7 shows the dynamics of mEGFP-Lifeact in HT1080 
cells and A2780 cells ± cRGDfV migrating on CDM. Online supplemental ma-
terial is available at http://www.jcb.org/cgi/content/full/jcb.201302041/
DC1. Additional data are available in the JCB DataViewer at http://dx.doi 
.org/10.1083/jcb.201302041.dv.
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Cluster 3.0 (version 1.50; C Clustering Library; de Hoon et al., 2004) and 
visualized using TreeView (version 1.1.6r2; Java; Saldanha, 2004).
Microscopy
For immunofluorescence imaging, cells were plated onto CDM for >4 h, 
treated with or without cRGDfV, and fixed in 4% paraformaldehyde. After 
permeabilization and blocking, cells were stained using primary (rabbit 
anti-RacGAP1, rabbit anti-IQGAP1, or mouse anti-FLAG) and Cy2- or Cy3- 
conjugated secondary antibodies as indicated. Images were captured on a 
spinning-disk confocal inverted microscope (Marianas; 3i) using a 63× ob-
jective lens (Plan Apochromat, NA 1.46) and SlideBook 5.0 software (3i). 
Linear adjustments to brightness and contrast were made using ImageJ 
(adjustments were equivalent for all channels between comparable images; 
National Institutes of Health).
For long-term time lapse, A2780 cells were plated onto CDM in 
normal culture medium for >4 h and imaged in the presence or absence 
of cRGDfV in a 37°C 5% CO2 atmosphere. Phase-contrast images were 
captured on an inverted microscope system (AS-MDW; Leica) using a 20× 
objective lens (HC Plan Fluotar Ph2, NA 0.50) every 10 min using a charge-
coupled device camera (CoolSNAP HQ; Photometrics) and Image Pro 6.3 
software (Media Cybernetics). Images and videos were analyzed using 
ImageJ (manual tracking plugin to determine speed/persistence).
For live-cell imaging of actin dynamics during invasive migration, 
A2780 and HT1080 cells transiently transfected with Lifeact-GFP were 
plated on CDM-coated glass-bottom dishes for 4 h. For optimal image reso-
lution, normal culture medium was replaced by Ham’s F12 (Gibco) con-
taining 25 mM Hepes in presence of 10% (vol/vol) FCS before addition of 
cRGDfV (>1 h) where appropriate for image and subsequent acquisition. 
Images were collected every 3 min at 37°C on a spinning-disk confocal in-
verted microscope (Marianas) using a 100× objective lens (Plan Apochro-
mat, NA 1.4) and SlideBook 5.0 software. For each protrusive event, the 
mean integrated density of Lifeact-GFP at protrusion sites was normalized 
to the mean integrated density of Lifeact-GFP in the whole cell.
For imaging of cells within FN-rich collagen gels, A2780 cells 
were embedded in the collagen gel and plated on glass-bottom dishes for 
30 min before overlay with growth media plus 30 ng/ml EGF. Before fixa-
tion, cells were allowed to invade in the presence or absence of cRGDfV 
for 24 h. Cells were stained using TRITC-phalloidin (Invitrogen) and imaged 
using an inverted confocal microscope (TCS SP5 Acousto-Optical Beam 
Splitter; Leica) and a 40× objective lens (HCX Plan Apochromat, NA 
1.25) with 1.7× confocal zoom using LCS software (Leica). Z sections 
were acquired every 0.4 µm. Maximum projections were produced using 
ImageJ, and 3D reconstructions were made using Imaris software (Bitplane 
Scientific Software). 2D shape analyses were performed using the ImageJ 
particle analyses plug-in using the maximum projection images, and the 
3D shape analyses were performed using the ImageJ plugin 3D Shape.
FLIM
FLIM is a well-established method for calculation of FRET efficiency, and 
because it involves measurement of the fluorescence lifetime of the donor 
molecule in FRET, it avoids many of the caveats associated with intensity-
based FRET measurements, including artifacts introduced by concentration 
of probes and donor bleed through (Becker, 2012). We used frequency 
domain FLIM to calculate FRET efficiency based on the polar plot method 
(Redford and Clegg, 2005). This method allows calculation of the nearest 
single lifetime for multiexponential donors such as CFP. For analysis of 
PKB/Akt, Rac, and RhoA activities, A2780 cells were transiently trans-
fected with Raichu probes (Akind-1711, Akind-1714 [Akind-3A], Raichu-
1011X [Rac1], Raichu-1012X [Rac1 G12V], Raichu-1013X [Rac1 T17N], 
Raichu-1237X, Raichu-1238X [Rho AQ63L], and Raichu-1239X [RhoA 
S19N]) and seeded onto CDM 20 h later. For optimal image resolution, 
normal culture medium was replaced by Ham’s F12 containing 25 mM 
Hepes in the presence of 10% FCS. After >4 h on CDM, cells were treated 
with cRGDfV for a further 1–2 h where necessary, and FLIM was per-
formed using a Marianas system equipped with a FLIM module (Lambert 
Instruments) and a 63× objective lens (Plan Apochromat, NA 1.46). Image 
capture and analysis were performed using SlideBook. FRET efficiency () 
was calculated using the formula  = 100 × [1  (DA/D)], in which D  
represents the lifetime of the donor (CFP), and DA represents the lifetime of 
the donor in the presence of the acceptor (CFP/YFP probe).
Inverted invasion assays
Inverted invasion assays were modified from those described previously 
(Hennigan et al., 1994). In brief, collagen I (final concentration 5 µg/ml; 
BD) supplemented with 25 µg/ml FN as indicated was allowed to polymerize 
JCB • VOLUME 202 • NUMBER 6 • 2013 934
Guilluy, C., R. Garcia-Mata, and K. Burridge. 2011. Rho protein crosstalk: 
another social network? Trends Cell Biol. 21:718–726. http://dx.doi 
.org/10.1016/j.tcb.2011.08.002
Hennigan, R.F., K.L. Hawker, and B.W. Ozanne. 1994. Fos-transformation acti-
vates genes associated with invasion. Oncogene. 9:3591–3600.
Ho, Y.D., J.L. Joyal, Z. Li, and D.B. Sacks. 1999. IQGAP1 integrates Ca2+/
calmodulin and Cdc42 signaling. J. Biol. Chem. 274:464–470. http://
dx.doi.org/10.1074/jbc.274.1.464
Humphries, J.D., A. Byron, and M.J. Humphries. 2006. Integrin ligands at 
a glance. J. Cell Sci. 119:3901–3903. http://dx.doi.org/10.1242/jcs 
.03098
Huveneers, S., and E.H.J. Danen. 2009. Adhesion signaling - crosstalk be-
tween integrins, Src and Rho. J. Cell Sci. 122:1059–1069. http://dx.doi 
.org/10.1242/jcs.039446
Hynes, R.O. 2002. Integrins: bidirectional, allosteric signaling machines. Cell. 
110:673–687. http://dx.doi.org/10.1016/S0092-8674(02)00971-6
Irie, H.Y., R.V. Pearline, D. Grueneberg, M. Hsia, P. Ravichandran, N. Kothari, 
S. Natesan, and J.S. Brugge. 2005. Distinct roles of Akt1 and Akt2 in 
regulating cell migration and epithelial–mesenchymal transition. J. Cell 
Biol. 171:1023–1034. http://dx.doi.org/10.1083/jcb.200505087
Itoh, R.E., K. Kurokawa, Y. Ohba, H. Yoshizaki, N. Mochizuki, and M. 
Matsuda. 2002. Activation of rac and cdc42 video imaged by fluores-
cent resonance energy transfer-based single-molecule probes in the 
membrane of living cells. Mol. Cell. Biol. 22:6582–6591. http://dx.doi 
.org/10.1128/MCB.22.18.6582-6591.2002
Jacquemet, G., M.J. Humphries, and P.T. Caswell. 2013a. Role of adhesion re-
ceptor trafficking in 3D cell migration. Curr. Opin. Cell Biol.
Jacquemet, G., M.R. Morgan, A. Byron, J.D. Humphries, C.K. Choi, C.S. Chen, 
P.T. Caswell, and M.J. Humphries. 2013b. Rac1 is deactivated at integ-
rin activation sites via an IQGAP1/filamin-A/RacGAP1 pathway. J. Cell 
Sci. http://dx.doi.org/10.1242/jcs.121988
Jameson, K.L., P.K. Mazur, A.M. Zehnder, J. Zhang, B. Zarnegar, J. Sage, and 
P.A. Khavari. 2013. IQGAP1 scaffold-kinase interaction blockade selec-
tively targets RAS-MAP kinase-driven tumors. Nat. Med. 19:626–630. 
http://dx.doi.org/10.1038/nm.3165
Johnson, M., M. Sharma, and B.R. Henderson. 2009. IQGAP1 regulation 
and roles in cancer. Cell. Signal. 21:1471–1478. http://dx.doi.org/10 
.1016/j.cellsig.2009.02.023
Kawashima, T., Y.C. Bao, Y. Nomura, Y. Moon, Y. Tonozuka, Y. Minoshima, 
T. Hatori, A. Tsuchiya, M. Kiyono, T. Nosaka, et al. 2006. Rac1 and a 
GTPase-activating protein, MgcRacGAP, are required for nuclear trans-
location of STAT transcription factors. J. Cell Biol. 175:937–946. http://
dx.doi.org/10.1083/jcb.200604073
Kawashima, T., Y.C. Bao, Y. Minoshima, Y. Nomura, T. Hatori, T. Hori, T. 
Fukagawa, T. Fukada, N. Takahashi, T. Nosaka, et al. 2009. A Rac 
GTPase-activating protein, MgcRacGAP, is a nuclear localizing sig-
nal-containing nuclear chaperone in the activation of STAT transcrip-
tion factors. Mol. Cell. Biol. 29:1796–1813. http://dx.doi.org/10.1128/ 
MCB.01423-08
Kitzing, T.M., Y. Wang, O. Pertz, J.W. Copeland, and R. Grosse. 2010. Formin-
like 2 drives amoeboid invasive cell motility downstream of RhoC. 
Oncogene. 29:2441–2448. http://dx.doi.org/10.1038/onc.2009.515
Legate, K.R., S.A. Wickström, and R. Fässler. 2009. Genetic and cell biological 
analysis of integrin outside-in signaling. Genes Dev. 23:397–418. http://
dx.doi.org/10.1101/gad.1758709
Lekomtsev, S., K.-C. Su, V.E. Pye, K. Blight, S. Sundaramoorthy, T. Takaki, 
L.M. Collinson, P. Cherepanov, N. Divecha, and M. Petronczki. 
2012. Centralspindlin links the mitotic spindle to the plasma mem-
brane during cytokinesis. Nature. 492:276–279. http://dx.doi.org/10 
.1038/nature11773
Lu, K.H., A.P. Patterson, L. Wang, R.T. Marquez, E.N. Atkinson, K.A. Baggerly, 
L.R. Ramoth, D.G. Rosen, J. Liu, I. Hellstrom, et al. 2004. Selection of 
potential markers for epithelial ovarian cancer with gene expression 
arrays and recursive descent partition analysis. Clin. Cancer Res. 
10:3291–3300. http://dx.doi.org/10.1158/1078-0432.CCR-03-0409
Machacek, M., L. Hodgson, C. Welch, H. Elliott, O. Pertz, P. Nalbant, A. Abell, 
G.L. Johnson, K.M. Hahn, and G. Danuser. 2009. Coordination of Rho 
GTPase activities during cell protrusion. Nature. 461:99–103. http://
dx.doi.org/10.1038/nature08242
Mataraza, J.M., M.W. Briggs, Z. Li, A. Entwistle, A.J. Ridley, and D.B. Sacks. 
2003. IQGAP1 promotes cell motility and invasion. J. Biol. Chem. 
278:41237–41245. http://dx.doi.org/10.1074/jbc.M304838200
Minoshima, Y., T. Kawashima, K. Hirose, Y. Tonozuka, A. Kawajiri, Y.C. 
Bao, X. Deng, M. Tatsuka, S. Narumiya, W.S. May Jr., et al. 2003. 
Phosphorylation by aurora B converts MgcRacGAP to a RhoGAP 
during cytokinesis. Dev. Cell. 4:549–560. http://dx.doi.org/10.1016/ 
S1534-5807(03)00089-3
Submitted: 7 February 2013
Accepted: 8 August 2013
References
Bastos, R.N., X. Penate, M. Bates, D. Hammond, and F.A. Barr. 2012. CYK4 inhib-
its Rac1-dependent PAK1 and ARHGEF7 effector pathways during cytoki-
nesis. J. Cell Biol. 198:865–880. http://dx.doi.org/10.1083/jcb.201204107
Becker, W. 2012. Fluorescence lifetime imaging—techniques and applications. 
J. Microsc. 247:119–136. http://dx.doi.org/10.1111/j.1365-2818.2012 
.03618.x
Brandt, D.T., C. Baarlink, T.M. Kitzing, E. Kremmer, J. Ivaska, P. Nollau, 
and R. Grosse. 2009. SCAI acts as a suppressor of cancer cell inva-
sion through the transcriptional control of beta1-integrin. Nat. Cell Biol. 
11:557–568. http://dx.doi.org/10.1038/ncb1862
Bridgewater, R.E., J.C. Norman, and P.T. Caswell. 2012. Integrin traffick-
ing at a glance. J. Cell Sci. 125:3695–3701. http://dx.doi.org/10.1242/ 
jcs.095810
Brown, M.D., and D.B. Sacks. 2006. IQGAP1 in cellular signaling: bridg-
ing the GAP. Trends Cell Biol. 16:242–249. http://dx.doi.org/10.1016/ 
j.tcb.2006.03.002
Canman, J.C., L. Lewellyn, K. Laband, S.J. Smerdon, A. Desai, B. Bowerman, 
and K. Oegema. 2008. Inhibition of Rac by the GAP activity of cen-
tralspindlin is essential for cytokinesis. Science. 322:1543–1546. http://
dx.doi.org/10.1126/science.1163086
Caswell, P., and J. Norman. 2008. Endocytic transport of integrins during cell 
migration and invasion. Trends Cell Biol. 18:257–263. http://dx.doi.org/ 
10.1016/j.tcb.2008.03.004
Caswell, P.T., H.J. Spence, M. Parsons, D.P. White, K. Clark, K.W. Cheng, 
G.B. Mills, M.J. Humphries, A.J. Messent, K.I. Anderson, et al. 2007. 
Rab25 associates with alpha5beta1 integrin to promote invasive migra-
tion in 3D microenvironments. Dev. Cell. 13:496–510. http://dx.doi 
.org/10.1016/j.devcel.2007.08.012
Caswell, P.T., M. Chan, A.J. Lindsay, M.W. McCaffrey, D. Boettiger, and J.C. 
Norman. 2008. Rab-coupling protein coordinates recycling of 51 in-
tegrin and EGFR1 to promote cell migration in 3D microenvironments. 
J. Cell Biol. 183:143–155. http://dx.doi.org/10.1083/jcb.200804140
Caswell, P.T., S. Vadrevu, and J.C. Norman. 2009. Integrins: masters and slaves 
of endocytic transport. Nat. Rev. Mol. Cell Biol. 10:843–853. http://
dx.doi.org/10.1038/nrm2799
Christoforides, C., E. Rainero, K.K. Brown, J.C. Norman, and A. Toker. 2012. 
PKD controls v3 integrin recycling and tumor cell invasive migration 
through its substrate Rabaptin-5. Dev. Cell. 23:560–572. http://dx.doi 
.org/10.1016/j.devcel.2012.08.008
Craig, R., and R.C. Beavis. 2003. A method for reducing the time required to 
match protein sequences with tandem mass spectra. Rapid Commun. 
Mass Spectrom. 17:2310–2316. http://dx.doi.org/10.1002/rcm.1198
Cukierman, E., R. Pankov, D.R. Stevens, and K.M. Yamada. 2001. Taking cell-
matrix adhesions to the third dimension. Science. 294:1708–1712. http://
dx.doi.org/10.1126/science.1064829
Danen, E.H.J., J. van Rheenen, W. Franken, S. Huveneers, P. Sonneveld, K. 
Jalink, and A. Sonnenberg. 2005. Integrins control motile strategy 
through a Rho–cofilin pathway. J. Cell Biol. 169:515–526. http://dx.doi 
.org/10.1083/jcb.200412081
Deakin, N.O., and C.E. Turner. 2011. Distinct roles for paxillin and Hic-5 in 
regulating breast cancer cell morphology, invasion, and metastasis. Mol. 
Biol. Cell. 22:327–341. http://dx.doi.org/10.1091/mbc.E10-09-0790
de Hoon, M.J.L., S. Imoto, J. Nolan, and S. Miyano. 2004. Open source cluster-
ing software. Bioinformatics. 20:1453–1454. http://dx.doi.org/10.1093/ 
bioinformatics/bth078
Dillon, R.L., R. Marcotte, B.T. Hennessy, J.R. Woodgett, G.B. Mills, and 
W.J. Muller. 2009. Akt1 and akt2 play distinct roles in the initiation 
and metastatic phases of mammary tumor progression. Cancer Res. 
69:5057–5064. http://dx.doi.org/10.1158/0008-5472.CAN-08-4287
Dozynkiewicz, M.A., N.B. Jamieson, I. Macpherson, J. Grindlay, P.V.E. van den 
Berghe, A. von Thun, J.P. Morton, C. Gourley, P. Timpson, C. Nixon, 
et al. 2012. Rab25 and CLIC3 collaborate to promote integrin recycling 
from late endosomes/lysosomes and drive cancer progression. Dev. Cell. 
22:131–145. http://dx.doi.org/10.1016/j.devcel.2011.11.008
Friedl, P., and S. Alexander. 2011. Cancer invasion and the microenviron-
ment: plasticity and reciprocity. Cell. 147:992–1009. http://dx.doi.org/ 
10.1016/j.cell.2011.11.016
Ghajar, C.M., H. Peinado, H. Mori, I.R. Matei, K.J. Evason, H. Brazier, D. 
Almeida, A. Koller, K.A. Hajjar, D.Y.R. Stainier, et al. 2013. The perivascu-
lar niche regulates breast tumour dormancy. Nat. Cell Biol. 15:807–817. 
http://dx.doi.org/10.1038/ncb2767
935Local Rac suppression promotes pseudopod extension • Jacquemet et al.
Simon, G.C., E. Schonteich, C.C. Wu, A. Piekny, D. Ekiert, X. Yu, G.W. 
Gould, M. Glotzer, and R. Prekeris. 2008. Sequential Cyk-4 binding 
to ECT2 and FIP3 regulates cleavage furrow ingression and abscis-
sion during cytokinesis. EMBO J. 27:1791–1803. http://dx.doi.org/10 
.1038/emboj.2008.112
Su, K.-C., T. Takaki, and M. Petronczki. 2011. Targeting of the RhoGEF Ect2 
to the equatorial membrane controls cleavage furrow formation dur-
ing cytokinesis. Dev. Cell. 21:1104–1115. http://dx.doi.org/10.1016/j 
.devcel.2011.11.003
Timpson, P., E.J. McGhee, J.P. Morton, A. von Kriegsheim, J.P. Schwarz, 
S.A. Karim, B. Doyle, J.A. Quinn, N.O. Carragher, M. Edward, et al. 
2011. Spatial regulation of RhoA activity during pancreatic cancer cell 
invasion driven by mutant p53. Cancer Res. 71:747–757. http://dx.doi 
.org/10.1158/0008-5472.CAN-10-2267
Vega, F.M., G. Fruhwirth, T. Ng, and A.J. Ridley. 2011. RhoA and RhoC have 
distinct roles in migration and invasion by acting through different targets. 
J. Cell Biol. 193:655–665. http://dx.doi.org/10.1083/jcb.201011038
Wang, S.M., L.L. Ooi, and K.M. Hui. 2011. Upregulation of Rac GTPase- 
activating protein 1 is significantly associated with the early recurrence 
of human hepatocellular carcinoma. Clin. Cancer Res. 17:6040–6051. 
http://dx.doi.org/10.1158/1078-0432.CCR-11-0557
White, D.P., P.T. Caswell, and J.C. Norman. 2007. v3 and 51 integrin 
recycling pathways dictate downstream Rho kinase signaling to regu-
late persistent cell migration. J. Cell Biol. 177:515–525. http://dx.doi 
.org/10.1083/jcb.200609004
Wickström, S.A., and R. Fässler. 2011. Regulation of membrane traffic by 
integrin signaling. Trends Cell Biol. 21:266–273. http://dx.doi.org/10 
.1016/j.tcb.2011.02.003
Wolf, K., I. Mazo, H. Leung, K. Engelke, U.H. von Andrian, E.I. Deryugina, A.Y. 
Strongin, E.-B. Bröcker, and P. Friedl. 2003. Compensation mechanism 
in tumor cell migration: mesenchymal–amoeboid transition after block-
ing of pericellular proteolysis. J. Cell Biol. 160:267–277. http://dx.doi 
.org/10.1083/jcb.200209006
Yoshizaki, H., Y. Ohba, K. Kurokawa, R.E. Itoh, T. Nakamura, N. Mochizuki, 
K. Nagashima, and M. Matsuda. 2003. Activity of Rho-family GTPases 
during cell division as visualized with FRET-based probes. J. Cell Biol. 
162:223–232. http://dx.doi.org/10.1083/jcb.200212049
Yoshizaki, H., N. Mochizuki, Y. Gotoh, and M. Matsuda. 2007. Akt-PDK1 
complex mediates epidermal growth factor-induced membrane protru-
sion through Ral activation. Mol. Biol. Cell. 18:119–128. http://dx.doi 
.org/10.1091/mbc.E06-05-0467
Yüce, O., A. Piekny, and M. Glotzer. 2005. An ECT2–centralspindlin complex 
regulates the localization and function of RhoA. J. Cell Biol. 170:571–
582. http://dx.doi.org/10.1083/jcb.200501097
Mishima, M., S. Kaitna, and M. Glotzer. 2002. Central spindle assembly and 
cytokinesis require a kinesin-like protein/RhoGAP complex with mi-
crotubule bundling activity. Dev. Cell. 2:41–54. http://dx.doi.org/10.1016/ 
S1534-5807(01)00110-1
Morgan, M.R., H. Hamidi, M.D. Bass, S. Warwood, C. Ballestrem, and M.J. 
Humphries. 2013. Syndecan-4 phosphorylation is a control point for inte-
grin recycling. Dev. Cell. 24:472–485. http://dx.doi.org/10.1016/j.devcel 
.2013.01.027
Moritz, A., Y. Li, A. Guo, J. Villén, Y. Wang, J. MacNeill, J. Kornhauser, K. 
Sprott, J. Zhou, A. Possemato, et al. 2010. Akt-RSK-S6 kinase signaling 
networks activated by oncogenic receptor tyrosine kinases. Sci. Signal. 
3:ra64. http://dx.doi.org/10.1126/scisignal.2000998
Moser, M., K.R. Legate, R. Zent, and R. Fässler. 2009. The tail of integrins, 
talin, and kindlins. Science. 324:895–899. http://dx.doi.org/10 
.1126/science.1163865
Muller, P.A.J., P.T. Caswell, B. Doyle, M.P. Iwanicki, E.H. Tan, S. Karim, 
N. Lukashchuk, D.A. Gillespie, R.L. Ludwig, P. Gosselin, et al. 2009. 
Mutant p53 drives invasion by promoting integrin recycling. Cell. 
139:1327–1341. http://dx.doi.org/10.1016/j.cell.2009.11.026
Muller, P.A.J., A.G. Trinidad, P. Timpson, J.P. Morton, S. Zanivan, P.V.E. 
van den Berghe, C. Nixon, S.A. Karim, P.T. Caswell, J.E. Noll, et al. 
2013. Mutant p53 enhances MET trafficking and signalling to drive 
cell scattering and invasion. Oncogene. 32:1252–1265. http://dx.doi 
.org/10.1038/onc.2012.148
Perkins, D.N., D.J. Pappin, D.M. Creasy, and J.S. Cottrell. 1999. Probability-
based protein identification by searching sequence databases using mass 
spectrometry data. Electrophoresis. 20:3551–3567. http://dx.doi.org/
10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551> 
3.0.CO;2-2
Pertz, O., L. Hodgson, R.L. Klemke, and K.M. Hahn. 2006. Spatiotemporal 
dynamics of RhoA activity in migrating cells. Nature. 440:1069–1072. 
http://dx.doi.org/10.1038/nature04665
Petrie, R.J., N. Gavara, R.S. Chadwick, and K.M. Yamada. 2012. Nonpolarized 
signaling reveals two distinct modes of 3D cell migration. J. Cell Biol. 
197:439–455. http://dx.doi.org/10.1083/jcb.201201124
Poincloux, R., O. Collin, F. Lizárraga, M. Romao, M. Debray, M. Piel, and P. 
Chavrier. 2011. Contractility of the cell rear drives invasion of breast 
tumor cells in 3D Matrigel. Proc. Natl. Acad. Sci. USA. 108:1943–1948. 
http://dx.doi.org/10.1073/pnas.1010396108
Psaila, B., and D. Lyden. 2009. The metastatic niche: adapting the foreign soil. 
Nat. Rev. Cancer. 9:285–293. http://dx.doi.org/10.1038/nrc2621
Rainero, E., P.T. Caswell, P.A.J. Muller, J. Grindlay, M.W. McCaffrey, Q. 
Zhang, M.J.O. Wakelam, K.H. Vousden, A. Graziani, and J.C. Norman. 
2012. Diacylglycerol kinase  controls RCP-dependent integrin traffick-
ing to promote invasive migration. J. Cell Biol. 196:277–295. http://dx.doi 
.org/10.1083/jcb.201109112
Ratheesh, A., G.A. Gomez, R. Priya, S. Verma, E.M. Kovacs, K. Jiang, N.H. 
Brown, A. Akhmanova, S.J. Stehbens, and A.S. Yap. 2012. Centralspindlin 
and -catenin regulate Rho signalling at the epithelial zonula adherens. 
Nat. Cell Biol. 14:818–828. http://dx.doi.org/10.1038/ncb2532
Redford, G.I., and R.M. Clegg. 2005. Polar plot representation for frequency- 
domain analysis of fluorescence lifetimes. J. Fluoresc. 15:805–815. 
http://dx.doi.org/10.1007/s10895-005-2990-8
Reticker-Flynn, N.E., D.F.B. Malta, M.M. Winslow, J.M. Lamar, M.J. Xu, G.H. 
Underhill, R.O. Hynes, T.E. Jacks, and S.N. Bhatia. 2012. A combinato-
rial extracellular matrix platform identifies cell-extracellular matrix inter-
actions that correlate with metastasis. Nat Commun. 3:1122. http://dx.doi 
.org/10.1038/ncomms2128
Reymond, N., J.H. Im, R. Garg, F.M. Vega, B. Borda d’Agua, P. Riou, S. Cox, F. 
Valderrama, R.J. Muschel, and A.J. Ridley. 2012. Cdc42 promotes tran-
sendothelial migration of cancer cells through 1 integrin. J. Cell Biol. 
199:653–668. http://dx.doi.org/10.1083/jcb.201205169
Ridley, A.J., M.A. Schwartz, K. Burridge, R.A. Firtel, M.H. Ginsberg, G. 
Borisy, J.T. Parsons, and A.R. Horwitz. 2003. Cell migration: integrat-
ing signals from front to back. Science. 302:1704–1709. http://dx.doi 
.org/10.1126/science.1092053
Sahai, E. 2007. Illuminating the metastatic process. Nat. Rev. Cancer. 7:737–
749. http://dx.doi.org/10.1038/nrc2229
Saldanha, A.J. 2004. Java Treeview—extensible visualization of microar-
ray data. Bioinformatics. 20:3246–3248. http://dx.doi.org/10.1093/ 
bioinformatics/bth349
Sanz-Moreno, V., G. Gadea, J. Ahn, H. Paterson, P. Marra, S. Pinner, E. 
Sahai, and C.J. Marshall. 2008. Rac activation and inactivation control 
plasticity of tumor cell movement. Cell. 135:510–523. http://dx.doi 
.org/10.1016/j.cell.2008.09.043
Shattil, S.J., C. Kim, and M.H. Ginsberg. 2010. The final steps of integrin activa-
tion: the end game. Nat. Rev. Mol. Cell Biol. 11:288–300. http://dx.doi 
.org/10.1038/nrm2871
